These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11878807)

  • 21. A continuous fluorimetric assay for tail-specific protease.
    Beebe KD; Pei D
    Anal Biochem; 1998 Oct; 263(1):51-6. PubMed ID: 9750142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relaxed specificity of matrix metalloproteinases (MMPS) and TIMP insensitivity of tumor necrosis factor-alpha (TNF-alpha) production suggest the major TNF-alpha converting enzyme is not an MMP.
    Black RA; Durie FH; Otten-Evans C; Miller R; Slack JL; Lynch DH; Castner B; Mohler KM; Gerhart M; Johnson RS; Itoh Y; Okada Y; Nagase H
    Biochem Biophys Res Commun; 1996 Aug; 225(2):400-5. PubMed ID: 8753775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and characterization of novel fluorogenic substrates of coagulation factor XIII-A.
    Hardes K; Zouhir Hammamy M; Steinmetzer T
    Anal Biochem; 2013 Nov; 442(2):223-30. PubMed ID: 23933241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substrate specificity and inducibility of TACE (tumour necrosis factor alpha-converting enzyme) revisited: the Ala-Val preference, and induced intrinsic activity.
    Black RA; Doedens JR; Mahimkar R; Johnson R; Guo L; Wallace A; Virca D; Eisenman J; Slack J; Castner B; Sunnarborg SW; Lee DC; Cowling R; Jin G; Charrier K; Peschon JJ; Paxton R
    Biochem Soc Symp; 2003; (70):39-52. PubMed ID: 14587281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cleavage specificity of human rhinovirus-2 2A protease for peptide substrates.
    Wang QM; Sommergruber W; Johnson RB
    Biochem Biophys Res Commun; 1997 Jun; 235(3):562-6. PubMed ID: 9207196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of peptides containing the cleavage sequence of pro-TNFalpha in assessing TACE activity of whole cells.
    Becker BF; Gilles S; Sommerhoff CP; Zahler S
    Biol Chem; 2002 Nov; 383(11):1821-6. PubMed ID: 12530549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New continuous and specific fluorometric assays for Pseudomonas aeruginosa elastase and LasA protease.
    Elston C; Wallach J; Saulnier J
    Anal Biochem; 2007 Sep; 368(1):87-94. PubMed ID: 17553454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of an internally quenched fluorescent substrate for Escherichia coli leader peptidase.
    Zhong W; Benkovic SJ
    Anal Biochem; 1998 Jan; 255(1):66-73. PubMed ID: 9448843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-alpha converting enzyme.
    Duan JJ; Lu Z; Wasserman ZR; Liu RQ; Covington MB; Decicco CP
    Bioorg Med Chem Lett; 2005 Jun; 15(12):2970-3. PubMed ID: 15908214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A continuous fluorimetric assay for aminopeptidase P detailed analysis of product inhibition.
    Stöckel-Maschek A; Stiebitz B; Koelsch R; Neubert K
    Anal Biochem; 2003 Nov; 322(1):60-7. PubMed ID: 14705781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial purification and characterization of a tumor necrosis factor-alpha converting activity.
    Robache-Gallea S; Bruneau JM; Robbe H; Morand V; Capdevila C; Bhatnagar N; Chouaib S; Roman-Roman S
    Eur J Immunol; 1997 May; 27(5):1275-82. PubMed ID: 9174621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure and functions of tumor necrosis factor-alpha converting enzyme.
    Mezyk R; Bzowska M; Bereta J
    Acta Biochim Pol; 2003; 50(3):625-45. PubMed ID: 14515145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitors.
    Cherney RJ; Duan JJ; Voss ME; Chen L; Wang L; Meyer DT; Wasserman ZR; Hardman KD; Liu RQ; Covington MB; Qian M; Mandlekar S; Christ DD; Trzaskos JM; Newton RC; Magolda RL; Wexler RR; Decicco CP
    J Med Chem; 2003 May; 46(10):1811-23. PubMed ID: 12723945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-hydroxyformamide peptidomimetics as TACE/matrix metalloprotease inhibitors: oral activity via P1' isobutyl substitution.
    Musso DL; Andersen MW; Andrews RC; Austin R; Beaudet EJ; Becherer JD; Bubacz DG; Bickett DM; Chan JH; Conway JG; Cowan DJ; Gaul MD; Glennon KC; Hedeen KM; Lambert MH; Leesnitzer MA; McDougald DL; Mitchell JL; Moss ML; Rabinowitz MH; Rizzolio MC; Schaller LT; Stanford JB; Tippin T; Warner JR; Whitesell LG; Wiethe RW
    Bioorg Med Chem Lett; 2001 Aug; 11(16):2147-51. PubMed ID: 11514157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New fluorescent substrates for metalloendopeptidases with internal quenching of fluorescence].
    Filippova IIu; Lysogorskaia EN; Oksenoĭt ES; Troshchenkova EP; Stepanov VM
    Bioorg Khim; 1988 Apr; 14(4):467-71. PubMed ID: 3422002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorogenic peptide substrates for carboxydipeptidase activity of cathepsin B.
    Stachowiak K; Tokmina M; Karpińska A; Sosnowska R; Wiczk W
    Acta Biochim Pol; 2004; 51(1):81-92. PubMed ID: 15094828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The growth hormone receptor interacts with its sheddase, the tumour necrosis factor-alpha-converting enzyme (TACE).
    Schantl JA; Roza M; Van Kerkhof P; Strous GJ
    Biochem J; 2004 Jan; 377(Pt 2):379-84. PubMed ID: 14519102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetic characterization of lysine-specific metalloendopeptidases from Grifola frondosa and Pleurotus ostreatus fruiting bodies.
    Nonaka T; Hashimoto Y; Takio K
    J Biochem; 1998 Jul; 124(1):157-62. PubMed ID: 9644258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective neurotensin-derived internally quenched fluorogenic substrates for neurolysin (EC 3.4.24.16): comparison with thimet oligopeptidase (EC 3.4.24.15) and neprilysin (EC 3.4.24.11).
    Oliveira V; Campos M; Hemerly JP; Ferro ES; Camargo AC; Juliano MA; Juliano L
    Anal Biochem; 2001 May; 292(2):257-65. PubMed ID: 11355859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of Protease Activities Using Fluorogenic Substrates.
    Santamaria S; Nagase H
    Methods Mol Biol; 2018; 1731():107-122. PubMed ID: 29318548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.